Amicus Therapeutics (Nasdaq: FOLD) has acquired Callidus Biopharma, a privately-held biologics company focused on developing best-in-class enzyme replacement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE